Zentrela Inc. is a Canadian neurotechnology pioneer and creator of the first true scientific method for measuring the actual psychoactive effects of cannabis. Zentrela is advancing the world’s understanding of cannabis by creating the largest scientific database of consumer cannabis experiences through Observational Studies. Our vision is to set the standard for measuring cannabis effects by becoming the most reliable and accurate provider of cannabis effect information. Our consumer research is powered by the Cognalyzer, our proprietary neurotechnology platform that uses advanced machine learning algorithms to analyze consumer EEG data. Zentrela Inc. was proudly founded in Hamilton, Ontario by the entrepreneur Israel Gasperin, with the support of Dr. Dan Bosnyak, a University of McMaster neuroscientist with +20 years of unique experience in EEG technology, Neuroscience and AI.